Lantern Pharma Inc (LTRN) Stock Price, Quote & News

Company Profile

Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1a clinical trial for the treatment of advanced or metastatic solid tumors, or unresectable or recurrent GBM, solid tumor, such as pancreatic, breast, bladder, and lung cancers, as well as glioblastoma and other central ner...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 277 1136

Website: www.lanternpharma.com

Address:

1920 McKinney Avenue, 7th Floor, Dallas, United States

SevenPhigs27 Aug. 4 at 2:09 PM

$LTRN New 13G GLTA

0 · Reply

Bulltrader988 Aug. 3 at 6:30 PM

$LTRN 👃👀 https://www.stocktitan.net/news/LTRN/lantern-pharma-nasdaq-ltrn-establishes-open-medicine-ai-as-a-z1verpqqaitb.html

0 · Reply

mankind1 Aug. 3 at 6:03 PM

$LTRN sleeping giant.

0 · Reply

AtariLynx Aug. 3 at 3:20 PM

$LTRN all good news, great price to buy!

0 · Reply

flychicken1991 Aug. 3 at 11:40 AM

$LTRN Positive (66%): The announcement could put light upward pressure on LTRN shares by adding perceived standalone value and financing or monetization optionality to its AI platform... Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/cd0ddc75a6b2ec39?utm_source=stocktwits&utm_medium=story_url

0 · Reply

BabetteCH Aug. 1 at 11:43 AM

$LTRN „BeOne Medicines“, „AstraZeneca“ or „Johnson & Johnson“? Asking for a friend… 😉

1 · Reply

BabetteCH Jul. 31 at 7:25 AM

$LTRN https://dallasinnovates.com/forte-biosciences-acquired-by-dutch-pharma-firm-for-2-2b/

0 · Reply

mankind1 Jul. 30 at 6:15 PM

$LTRN Still time to buy

0 · Reply

BabetteCH Jul. 30 at 5:29 PM

$LTRN One more interesting point: LTRN had announced a withZeta investor update for the first half of June, but it appears that update never happened. Just a delay, or has something changed strategically behind the scenes? WholeCo-Deal?

0 · Reply

BabetteCH Jul. 30 at 5:17 PM

$LTRN Could $LTRN be a takeover candidate? LP-300 is showing promising results. So why license LP-300 and pay upfront, milestones and royalties if a large pharma could potentially buy the entire company for 125M — and get LP-184, LP-284, withZeta and the rest of the pipeline too? Could buying Lantern simply be cheaper than licensing its lead asset? Asking for a friend… 😉

1 · Reply